Literature DB >> 34324189

Neurotransmitter Release of Reprogrammed Cells Using Electrochemical Detection Methods.

Andreas Heuer1.   

Abstract

The detection of neurotransmitter release from reprogrammed human cell is an important demonstration of their functionality. Electrochemistry has the distinct advantages over alternative methods that it allows for the measuring of the analyte of interest at a high temporal resolution. This is necessary for fast events, such as neurotransmitter release and reuptake, which happen in the order of milliseconds to seconds. The precise description of these kinetic events can lead to insights into the function of cells in health and disease and allows for the exploration of events that might be missed using methods that look at absolute concentration values or methods that have a slower sampling rate. In the present chapter, we describe the use of constant potential amperometry and enzyme-coated multielectrode arrays for the detection of glutamate in vitro. These biosensors have the distinct advantage of "self-referencing," a method providing high selectivity while retaining outstanding temporal resolution. Here, we provide a step-by-step user guide for a commercially available system and its application for in vitro systems such as reprogrammed cells.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Amperometry; Astrocytes; Biosensor; Electrochemistry; Enzyme-based; Glutamate; In vitro; MEA; Neurotransmitter reuptake; Reprogramming; Stem cells

Year:  2021        PMID: 34324189     DOI: 10.1007/978-1-0716-1601-7_14

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  38 in total

1.  Direct conversion of human fibroblasts to dopaminergic neurons.

Authors:  Ulrich Pfisterer; Agnete Kirkeby; Olof Torper; James Wood; Jenny Nelander; Audrey Dufour; Anders Björklund; Olle Lindvall; Johan Jakobsson; Malin Parmar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-06       Impact factor: 11.205

Review 2.  The role of glutamate in neurotransmission and in neurologic disease.

Authors:  J T Greenamyre
Journal:  Arch Neurol       Date:  1986-10

Review 3.  The role of glutamate in anxiety and related disorders.

Authors:  Bernadette M Cortese; K Luan Phan
Journal:  CNS Spectr       Date:  2005-10       Impact factor: 3.790

Review 4.  The role of glutamate in epilepsy and other CNS disorders.

Authors:  B S Meldrum
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

Review 5.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders.

Authors:  Gerard Sanacora; Carlos A Zarate; John H Krystal; Husseini K Manji
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

6.  Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.

Authors:  J D Rothstein; L J Martin; R W Kuncl
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

Review 7.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease.

Authors:  A J Cross; P Slater; G P Reynolds
Journal:  Neurosci Lett       Date:  1986-06-18       Impact factor: 3.046

9.  Glutamate, learning and dementia-selection of evidence.

Authors:  W Danysz; T Archer
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

10.  Direct conversion of fibroblasts to functional neurons by defined factors.

Authors:  Thomas Vierbuchen; Austin Ostermeier; Zhiping P Pang; Yuko Kokubu; Thomas C Südhof; Marius Wernig
Journal:  Nature       Date:  2010-01-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.